Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.35 USD
Change Today -0.01 / -0.42%
Volume 31.6K
CLSN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for celsion corp (CLSN)

Although debt as a percent of total capital increased at Celsion Corp. over the last fiscal year to 22.82%, it is still in-line with the Biotechnology industry's norm. Additionally, there are enough liquid assets to satisfy current obligations.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents20.115.05.712.7
Short-Term Investments10.28.037.224.2
TOTAL CASH AND SHORT TERM INVESTMENTS30.323.042.936.9
Other Receivables0.20.20.20.2
TOTAL RECEIVABLES0.20.20.20.2
Other Current Assets1.00.40.70.4
TOTAL CURRENT ASSETS31.523.643.837.5
Gross Property Plant and Equipment1.42.02.12.8
Accumulated Depreciation-0.6-0.9-1.3-1.6
NET PROPERTY PLANT AND EQUIPMENT0.81.10.81.2
Goodwill------2.0
Deferred Charges, Long Term--0.30.80.1
Other Intangibles0.0----25.8
Other Long-Term Assets0.30.30.20.2
TOTAL ASSETS32.625.445.766.7
    
LIABILITIES & EQUITY    
Accounts Payable4.02.31.53.5
Accrued Expenses0.80.41.01.6
Current Portion of Long-Term Debt/Capital Lease0.11.40.03.7
Other Current Liabilities, Total1.20.81.70.9
Unearned Revenue, Current----0.50.5
TOTAL CURRENT LIABILITIES6.25.04.710.1
Long-Term Debt0.13.75.06.1
Unearned Revenue, Non-Current----4.03.5
Other Non-Current Liabilities0.24.70.514.2
TOTAL LIABILITIES6.513.414.133.9
Common Stock0.30.10.10.2
Additional Paid in Capital153.2171.0203.1229.8
Retained Earnings-124.2-156.3-169.3-195.1
Treasury Stock-2.9-2.7-2.4-2.1
Comprehensive Income and Other-0.3-0.10.00.0
TOTAL COMMON EQUITY26.212.031.532.8
TOTAL EQUITY26.212.031.532.8
TOTAL LIABILITIES AND EQUITY32.625.445.766.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLSN:US $2.35 USD -0.01

CLSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Medifocus Inc C$0.12 CAD -0.015
Perseon Corp $2.03 USD -0.04
View Industry Companies
 

Industry Analysis

CLSN

Industry Average

Valuation CLSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 94.0x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELSION CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.